Arginase 1/ARG1/liver Arginase Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-54621
Key Product Details
Species Reactivity
Validated:
Human, Mouse
Cited:
Human, Mouse
Applications
Validated:
Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Cited:
IF/IHC, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
1 mg/ml
Product Specifications
Immunogen
Synthetic peptides corresponding to ARG1(arginase, liver) The peptide sequence was selected from the N terminal of ARG1 (NP_000036). Peptide sequence HSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLK. The peptide sequence for this immunogen was taken from within the described region.
Reactivity Notes
Human reactivity reported in scientific literature (Andreou KE et al).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Theoretical MW
35 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for Arginase 1/ARG1/liver Arginase Antibody
Western Blot: Arginase 1/ARG1/liver Arginase Antibody [NBP1-54621]
Western Blot: Arginase 1/ARG1/liver Arginase Antibody [NBP1-54621] - Jurkat cell lysate, concentration 5.0ug/ml.Immunohistochemistry-Paraffin: Arginase 1/ARG1/liver Arginase Antibody [NBP1-54621]
Immunohistochemistry-Paraffin: Arginase 1/ARG1/liver Arginase Antibody [NBP1-54621] - Human Lung Alveolar cells (indicated with arrows), 4-8ug/ml.Immunohistochemistry: Arginase 1/ARG1/liver Arginase Antibody [NBP1-54621] -
Immunohistochemistry: Arginase 1/ARG1/liver Arginase Antibody [NBP1-54621] - Genetic deletion of IL-6 results in less fibrosis and increased remodeling at a chronic time point. A) Anti-Arginase 1/ARG1/liver Arginase immunohistochemistry staining results (n = 4-5; ∗P = .0210) and representative slides. The number of Arg1+ cells, a marker for prohealing monocytes and macrophages, was less in the IL-6-/- model. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/35647566/) licensed under a CC-BY license.Applications for Arginase 1/ARG1/liver Arginase Antibody
Application
Recommended Usage
Immunohistochemistry
4-8 ug/ml
Immunohistochemistry-Paraffin
4-8 ug/ml
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Arginase 1/ARG1
Arginase and nitric oxidase synthase (NOS) compete for the same L-arginine substrate, creating a delicate balance between pathways (1). Furthermore, bioavailability of L-arginine and ARG1 expression has been implicated in several pathologies including vascular disease, neuronal disease, cardiovascular disease, immune dysfunction, inflammation, and cancer (1,3-5). For instance, ARG1 functions as a macrophage marker, defining the M2 population, while inducible nitric oxide synthase (iNOS) characterizes the M1 population; impaired M1/M2 polarization and changes in ARG1 expression is observed in diseases such as arteriogenesis, asthma, pulmonary fibrosis, and inflammatory bowel disease (1,3). In humans, arginase deficiency, known as argininemia, is an autosomal recessive metabolic disorder characterized by elevated ammonia (hyperammonemia) levels and arginine accumulation (6). Given that many arginase-associated diseases are characterized by upregulation in expression of ARG1, ARG2, or both, arginase inhibitors are currently being studied as a potential therapeutic approach (1,4).
References
1. S Clemente, G., van Waarde, A., F Antunes, I., Domling, A., & H Elsinga, P. (2020). Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21155291
2. Uniprot (P05089)
3. Kieler, M., Hofmann, M., & Schabbauer, G. (2021). More than just protein building blocks: How amino acids and related metabolic pathways fuel macrophage polarization. The FEBS Journal. Advance online publication. https://doi.org/10.1111/febs.15715
4. Shosha, E., Fouda, A. Y., Narayanan, S. P., Caldwell, R. W., & Caldwell, R. B. (2020). Is the Arginase Pathway a Novel Therapeutic Avenue for Diabetic Retinopathy?. Journal of Clinical Medicine. https://doi.org/10.3390/jcm9020425
5. Correale J. (2021). Immunosuppressive Amino-Acid Catabolizing Enzymes in Multiple Sclerosis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2020.600428
6. Morales, J. A., & Sticco, K. L. (2020). Arginase Deficiency. In StatPearls. StatPearls Publishing.
Long Name
Liver-Type Arginase
Alternate Names
AI, ARG1, Arginase-1, Liver Arginase, PGIF, Type I Arginase
Entrez Gene IDs
383 (Human)
Gene Symbol
ARG1
UniProt
Additional Arginase 1/ARG1 Products
Product Documents for Arginase 1/ARG1/liver Arginase Antibody
Product Specific Notices for Arginase 1/ARG1/liver Arginase Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...